COVID-19 vaccines could be available in US by December 11 ─FDA Adviser

*Distribution plans likely will fall on the US Army’s shoulders, and CVS stores could also be involved

Isola Moses | ConsumerConnect

As the Coronavirus (COVID-19) pandemic currently hits harder with mores virus cases in the second wave of the damaging virus in the United States (US), there seems good news after all.

A US Food and Drug Administration (FDA) advisor says Americans might be able to start getting COVID-19 vaccines as early as Friday, December 11, 2020.

Dr. James Hildreth, an FDA and Vaccines Adviser President and Chief Executive Officer (CEO) of Meharry Medical College, told NBC News, that the agency may issue an emergency-use authorisation to Pfizer’s and BioNTech’s vaccine after a meeting of experts takes place on Thursday.

That approval could go into effect the very next day, said Hildreth.

Report indicates both companies had earlier been given the greenlight to fast-track their vaccines by the FDA in mid-July 2020.

Dr. Moncef Slaoui, Head of the White House’s Coronavirus vaccine effort, also confirmed Hildreth’s perspective.

He stated in an interview on CBS News ‘Face the Nation’, that he also expects the FDA to approve the shot.

He said shipments will likely start as soon as approval is given.

When Hildreth was asked about the lack of a “clear and consistent plan” to distribute the vaccines and why Americans should have any confidence in the possibility, he put the onus on the US Army.

He disclosed it, or one of its generals would be responsible for the logistics.

The Head of the White House’s Coronavirus vaccine team said: “One thing that our military does well is large-scale mobilisations like this.”

Hildreth also gave a nice plug for CVS, saying that the company’s stores could play a big part in distribution due to how many there are throughout the country.

According to him, “I also think that (Americans) should know that drug companies such as CVS are involved.

“CVS stores, if you look at them in total, 80 percent of our population lives within three miles of a CVS store and that’s one example of how we’re mobilising, taking advantage of existing infrastructure to make sure we get this right.

“I think Americans can be confident that it’s going to be distributed and done very well.”

As regards confidence in the vaccine itself, and regardless of access, many consumers may not be lining up to get inoculated when the time comes.

A recent poll showed that 40 percent of Americans have little to no confidence in a vaccine.

However, Hildreth said the FDA had spent a “lot of time” dealing with that low level of buy-in.

He noted: “My response would be a couple of things. The fast speed of the (development) of this vaccine is related to technology, existing infrastructure, and really incredible science.

“The other thing is that we’re identifying trusted messengers, making sure they are confident in the vaccine and allowing them to be the ones who are conveying the messages to the minority communities.

“We think that’s going to work. We need to give them agency, the ability to make a decision for themselves, and that requires giving them sufficient information. We’re confident we can do that.”

Kindly Share This Story